William F. Doyle - Mar 3, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Executive Chairman, Director
Signature
By: /s/ Steven Robbins, Attorney in fact for William F. Doyle
Stock symbol
NVCR
Transactions as of
Mar 3, 2022
Transactions value $
$1,175,083
Form type
4
Date filed
3/7/2022, 05:21 PM
Previous filing
Dec 2, 2021
Next filing
Mar 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $1.18M +14.6K $80.59 14.6K Mar 3, 2022 Ordinary Shares 14.6K $80.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options to buy 14,581 ordinary shares will vest and become exercisable in equal installments on each of March 1, 2023 and 2024, subject to the reporting person's continued employment through such dates.